Veterinary Medicine Information website

Poulvac Marek CVI + HVT

Authorised
  • Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live
  • Turkey herpesvirus, strain FC-126 (cell-associated), Live
Download as PDF

Product identification

Medicine name:
Poulvac Marek CVI + HVT
Active substance:
  • Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live
  • Turkey herpesvirus, strain FC-126 (cell-associated), Live
Target species:
  • Chicken
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live
    2.90
    log10 50% cell culture infectious dose
    /
    0.20
    millilitre(s)
  • Turkey herpesvirus, strain FC-126 (cell-associated), Live
    1000.00
    plaque forming unit
    /
    0.20
    millilitre(s)
Pharmaceutical form:
  • Concentrate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken
      • Meat and offal
        0
        day
      • Egg
        0
        day
  • Subcutaneous use
    • Chicken
      • Meat and offal
        0
        day
      • Egg
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD03
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Package description:
  • Poulvac Marek Diluent: PVC plastic bags containing 400 ml
  • Poulvac Marek CVI+HVT vaccine concentrate: Liquid nitrogen containers of n 2000-dose ampoules. The ampoules are stored in liquid nitrogen containers in a cane (5 ampoules per cane).
  • Poulvac Marek CVI+HVT vaccine concentrate: Liquid nitrogen containers of n 1000-dose ampoules. The ampoules are stored in liquid nitrogen containers in a cane (5 ampoules per cane).
  • Poulvac Marek Diluent: PVC plastic bags containing 1000 ml
  • Poulvac Marek Diluent: PVC plastic bags containing 200 ml
  • Poulvac Marek Diluent: Type II glass vial containing 200 ml. plastic bag or carton box with 10 glass bottles.
  • Poulvac Marek Diluent: Type II glass vial of 400 ml. plastic bag or carton box with 10 glass bottles.
  • Poulvac Marek CVI + HVT 800 ml bag

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Manufacturing & Research Spain S.L.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V232364
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0102/001
Concerned member states:
  • Belgium
  • Cyprus
  • Denmark
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Portugal
  • Slovenia
  • Spain

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 20/08/2025
Download
Dutch (PDF)
Published on: 20/08/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 20/08/2025
Download
German (PDF)
Published on: 20/08/2025
Download
Dutch (PDF)
Published on: 20/08/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 20/08/2025
Download
German (PDF)
Published on: 20/08/2025
Download
Dutch (PDF)
Published on: 20/08/2025
Download